Disruption of Circadian Rhythms Accelerates Development of Diabetes through Pancreatic Beta-Cell Loss and Dysfunction
Open accessAbstract
Type 2 diabetes mellitus (T2DM) is complex metabolic disease that arises as a consequence of interactions between genetic predisposition and environmental triggers. One recently described environmental trigger associated with development of T2DM is disturbance of circadian rhythms due to shift work, sleep loss, or nocturnal lifestyle. However, the underlying mechanisms behind this association are largely unknown. To address this, the authors examined the metabolic and physiological consequences of experimentally controlled circadian rhythm disruption in wild-type (WT) Sprague Dawley and diabetes-prone human islet amyloid polypeptide transgenic (HIP) rats: a validated model of T2DM. WT and HIP rats at 3 months of age were exposed to 10 weeks of either a normal light regimen (LD: 12:12-h light/dark) or experimental disruption in the light-dark cycle produced by either (1) 6-h advance of the light cycle every 3 days or (2) constant light protocol. Subsequently, blood glucose control, beta-cell function, beta-cell mass, turnover, and insulin sensitivity were examined. In WT rats, 10 weeks of experimental disruption of circadian rhythms failed to significantly alter fasting blood glucose levels, glucose-stimulated insulin secretion, beta-cell mass/turnover, or insulin sensitivity. In contrast, experimental disruption of circadian rhythms in diabetes-prone HIP rats led to accelerated development of diabetes. The mechanism subserving early-onset diabetes was due to accelerated loss of beta-cell function and loss of beta-cell mass attributed to increases in beta-cell apoptosis. Disruption of circadian rhythms may increase the risk of T2DM by accelerating the loss of beta-cell function and mass characteristic in T2DM.
AI snapshot
Written from the paper’s full text.
TL;DR
Experimental disruption of circadian rhythms accelerated diabetes development in diabetes-prone HIP rats but not wild-type rats. The effect was driven by beta-cell loss and dysfunction, with no change in insulin sensitivity.
Key findings
- In WT rats, 10 weeks of circadian disruption (constant light or 6-h light advance every 3 days) did not significantly alter fasting glucose, glucose- or arginine-stimulated insulin secretion, beta-cell mass/turnover, or insulin sensitivity.
- In diabetes-prone HIP rats, circadian disruption led to accelerated hyperglycemia; at ~5 months, HIP rats had elevated plasma glucose versus WT (118 ± 2 vs. 107 ± 2, p < 0.01), with more pronounced hyperglycemia in the HIP constant-light group (p < 0.05 for LD vs. LL and 6-h ADV).
- HIP rats exposed to circadian disruption showed further deterioration in glucose-stimulated insulin secretion (~65% vs. LD, p < 0.05) and arginine-stimulated insulin secretion (~50% vs. LD, p < 0.05).
- Beta-cell fractional area and mass fell by ~40% versus LD (p < 0.05), associated with increased beta-cell apoptosis (p < 0.05 vs. LD) but no change in beta-cell replication; whole-body insulin sensitivity was comparable across light regimens in both WT and HIP rats.
Methods
- Male Sprague Dawley WT (n = 43) and diabetes-prone human islet amyloid polypeptide transgenic HIP (n = 33) rats, 3 months old, were assigned for 10 weeks to normal 12:12-h light/dark, 6-h advance of the light cycle every 3 days, or 24-h constant light.
- Circadian disruption was validated by locomotor activity recordings and plasma melatonin rhythms; metabolic studies included hyperglycemic clamp with arginine bolus, hyperinsulinemic-euglycemic clamp, and pancreatic immunohistochemistry/immunofluorescence for beta-cell mass, apoptosis (TUNEL), and replication (Ki-67).
- Statistical analysis used ANOVA with Fisher post-hoc where appropriate; significance set at p < 0.05.
Limitations
- The paper states that the in vivo animal model precludes direct assessment of whether impaired insulin secretion is a direct consequence of beta-cell loss, beta-cell dysfunction, or a combination of both.
- The paper notes that disrupted feeding behavior associated with constant light and 6-h advances might have influenced results and that additional studies are needed to evaluate this.
- Evident from the text: findings are from male rats only, use a transgenic diabetes-prone model, and involve a 10-week exposure; human relevance is inferential.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 46 cited sources checked · 0 supported · 0 flagged
- Findingown data
Accelerated development of hyperglycemia in HIP rats exposed to constant light or 6-h light advances was not associated with a significant increase in body weight versus normal light-dark conditions.
“Accelerated development of hyperglycemia in HIP rats exposed to LL or 6-h ADV was not associated with a significant increase in body weight versus LD (Fig. 2D).”
Quote in the paperNot a substantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter fasting blood glucose concentrations.
“In WT rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter fasting blood glucose concentrations as well as body weight, implying failure to modify regulation of glucose metabolism (Fig. 2A,C).”
Quote in the paperNot a substantial claim - Findingown data
The decline in beta-cell mass following exposure of HIP rats to LL and 6-h ADV light regimens was associated with an increased rate of beta-cell apoptosis (p < 0.05 vs LD).
“This decline in beta-cell mass following exposure to LL and 6-h ADV light regimens was associated with an increased rate of beta-cell apoptosis (p < 0.05 vs. LD; Fig. 4J–L and Fig. 5H) but no change in beta-cell replication (Fig. 4P-R and Fig. 5G).”
Quote in the paperSubstantial claim - Findingown data
In HIP rats, disruption of circadian rhythms by LL and 6-h ADV led to a significant further deterioration in glucose-stimulated insulin secretion (~65% compared to LD; p < 0.05).
“HIP rats, disruption of circadian rhythms (LL and 6-h ADV) led to a significant further deterioration in glucose-stimulated (~65% compared to LD; p < 0.05) and arginine-stimulated (~50% compared to LD; p < 0.05) insulin secretion (Fig. 3D–H).”
Quote in the paperSubstantial claim - Findingown data
In diabetes-prone HIP rats, disruption of circadian rhythms by constant light or 6-h light advances leads to a significant further deterioration in glucose-stimulated insulin secretion, approximately 65% compared with normal light-dark conditions.
“However, in contrast to WT rats, in diabetes-prone HIP rats, disruption of circadian rhythms (LL and 6-h ADV) led to a significant further deterioration in glucose-stimulated (~65% compared to LD; p <”
Quote in the paperSubstantial claim
- Findingown data
In normal light-dark conditions, rats' melatonin secretion demonstrates a typical robust nighttime rise with elevated plasma melatonin concentrations at 2200 and 0500 h.
“In LD conditions, rats’ melatonin secretion demonstrated a typical robust nighttime rise with elevated plasma melatonin concentrations at 2200 and 0500 h (Fig. 1D; p < 0.001).”
Quote in the paperNot a substantial claim - Findingown data
Melatonin rhythms are disrupted in animals exposed to either 10 weeks of constant light or 6-h light advances.
“Melatonin rhythms were disrupted in animals exposed to either 10 weeks of LL or 6-h ADV (p = 0.5; Fig. 1E,F).”
Quote in the paperSubstantial claim - Findingown data
Experimental disruption of circadian rhythms by constant light or 6-h light advances in HIP rats leads to accelerated development and maintenance of hyperglycemia.
“However, experimental disruption of circadian rhythms (LL and 6-h ADV) led to accelerated development and maintenance of hyperglycemia, which was more pronounced in the HIP LL group (Fig. 2B; p < 0.05 for LD vs. LL and 6-h ADV).”
Quote in the paperSubstantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter arginine-stimulated insulin secretion.
“There was no effect of disrupted circadian light rhythms in WT rats on either glucose- or arginine-stimulated insulin secretion (p = 0.71 and p = 0.96, respectively vs. LD; Fig. 3B–F).”
Quote in the paperSubstantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter beta-cell mass or turnover.
“In WT rats, 10 weeks of experimental disruption of circadian rhythms failed to significantly alter fasting blood glucose levels, glucose-stimulated insulin secretion, beta-cell mass/turnover, or insulin sensitivity.”
Quote in the paperSubstantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter body weight.
“In WT rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter fasting blood glucose concentrations as well as body weight, implying failure to modify regulation of glucose metabolism (Fig. 2A,C).”
Quote in the paperNot a substantial claim - Findingown data
In HIP rats, disruption of circadian rhythms by LL and 6-h ADV led to a significant further deterioration in arginine-stimulated insulin secretion (~50% compared to LD; p < 0.05).
“HIP rats, disruption of circadian rhythms (LL and 6-h ADV) led to a significant further deterioration in glucose-stimulated (~65% compared to LD; p < 0.05) and arginine-stimulated (~50% compared to LD; p < 0.05) insulin secretion (Fig. 3D–H).”
Quote in the paperSubstantial claim - Findingown data
In WT rats, beta-cell turnover (replication and apoptosis) was not altered in LL and 6-h ADV groups compared to LD.
“in WT rats, beta-cell fractional area, beta-cell mass, and beta-cell turnover (replication and apoptosis) were not altered in LL and 6-h ADV groups compared to LD (Fig. 4A–O and Fig. 5A–F).”
Quote in the paperSubstantial claim - Findingown data
The accelerated development of hyperglycemia in HIP rats exposed to constant light or 6-h light advances is more pronounced in the HIP constant-light group than in the 6-h advance group.
“However, experimental disruption of circadian rhythms (LL and 6-h ADV) led to accelerated development and maintenance of hyperglycemia, which was more pronounced in the HIP LL group (Fig. 2B; p < 0.05 for LD vs. LL and 6-h ADV).”
Quote in the paperNot a substantial claim - Findingown data
Chronic exposure of HIP rats to LL or 6-h ADV led to a further reduction in beta-cell mass by ~40% compared to LD (p < 0.05).
“chronic exposure of HIP rats to LL or 6-h ADV led to a further reduction in the beta-cell fractional area and beta-cell mass by ~40% compared to LD (p < 0.05; Fig. 4D-F and Fig. 5C,D).”
Quote in the paperSubstantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter insulin sensitivity.
“In WT rats, 10 weeks of experimental disruption of circadian rhythms failed to significantly alter fasting blood glucose levels, glucose-stimulated insulin secretion, beta-cell mass/turnover, or insulin sensitivity.”
Quote in the paperSubstantial claim - Findingown data
In wild-type rats, 10 weeks of experimental disruption of circadian rhythms did not significantly alter glucose-stimulated insulin secretion.
“There was no effect of disrupted circadian light rhythms in WT rats on either glucose- or arginine-stimulated insulin secretion (p = 0.71 and p = 0.96, respectively vs. LD; Fig. 3B–F).”
Quote in the paperSubstantial claim - Findingown data
Whole-body insulin sensitivity, assessed by mean glucose infusion rates during hyperinsulinemic clamp, was comparable and not significantly different among all light regimens in both WT and HIP rats.
“Whole-body insulin sensitivity, assessed by the mean glucose infusion rates during the hyperinsulinemic clamp, was comparable and not significantly different among all light regimens in both WT and HIP rats (Fig. 6E–H)”
Quote in the paperSubstantial claim - Findingown data
Prolonged exposure to either constant light or chronic light advances results in arrhythmicity of locomotor behavior in rats.
“while rats in the LD cycle maintained robust diurnal activity rhythms, prolonged exposure to either LL or chronic light advances resulted in arrhythmicity of locomotor behavior (Fig. 1A–C).”
Quote in the paperSubstantial claim - Findingcitation
HIP rats at 5 months of age exhibit a ~2-fold increased rate of beta-cell apoptosis compared to WT counterparts.
“As previously reported, HIP rats at 5 months of age (age of rats at the end of the 10-week study period) already exhibit a ~2-fold increased rate of beta-cell apoptosis compared to their WT counterparts (Fig. 5).”
Quote in the paperNot a substantial claim - Findingown data
HIP rats at the end of the 10-week study period, approximately 5 months of age, exhibit modestly elevated plasma glucose levels compared with wild-type rats (118 ± 2 vs. 107 ± 2, p < 0.01).
“HIP rats at the end of the 10-week study period (~5 months of age) already exhibited modestly elevated plasma glucose levels compared to WT (118 ± 2 vs. 107 ± 2, p < 0.01; Fig. 2).”
Quote in the paperNot a substantial claim - Findingown data
Circadian disruption brought about by frequent shifts in the light schedule or by LL led to accelerated development of diabetes in diabetes-prone HIP rats.
“We report that circadian disruption brought about by frequent shifts in the light schedule or by LL led to accelerated development of diabetes in diabetes-prone HIP rats”
Quote in the paperSubstantial claim- Rests on an assumption: The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
- Rests on an assumption: Circadian disruption induced by LL and 6-h ADV in rats models circadian misalignment in humans, such as that caused by shift work.
- Findingown data
The decline in beta-cell mass following exposure of HIP rats to LL and 6-h ADV light regimens was not associated with a change in beta-cell replication.
“This decline in beta-cell mass following exposure to LL and 6-h ADV light regimens was associated with an increased rate of beta-cell apoptosis (p < 0.05 vs. LD; Fig. 4J–L and Fig. 5H) but no change in beta-cell replication (Fig. 4P-R and Fig. 5G).”
Quote in the paperSubstantial claim - Findingown data
Chronic exposure of HIP rats to LL or 6-h ADV led to a further reduction in beta-cell fractional area by ~40% compared to LD (p < 0.05).
“chronic exposure of HIP rats to LL or 6-h ADV led to a further reduction in the beta-cell fractional area and beta-cell mass by ~40% compared to LD (p < 0.05; Fig. 4D-F and Fig. 5C,D).”
Quote in the paperSubstantial claim - Findingown data
Experimental disruption of circadian rhythms accelerated the development of diabetes only in rats characterized by a predisposition to beta-cell failure.
“Our data support this postulate by revealing that experimental disruption of circadian rhythms accelerated the development of diabetes only in rats characterized by a predisposition to beta-cell failure”
Quote in the paperSubstantial claim- Rests on an assumption: The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
- Findingnone given
Circadian misalignment had no discernible effect on beta-cell function or mass in WT animals.
“where circadian misalignment had no discernable effect on beta-cell function or mass in WT animals.”
Quote in the paperSubstantial claim - Premisecitation
The decline in glucose-stimulated insulin secretion in type 2 diabetes mellitus has been attributed to a defect in beta-cell function and the loss of beta-cell mass due to increased beta-cell apoptosis.
“The decline in glucose-stimulated insulin secretion has been attributed to a defect in beta-cell function and the loss of beta-cell mass due to increased beta-cell apoptosis (Butler et al., 2003; Perley and Kipnis, 1967).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Butler et al., 2003
Not checked in the free run.
- cites Perley and Kipnis, 1967
Not checked in the free run.
- Interpretationown data
Experimental disruption of circadian rhythms in diabetes-prone HIP rats leads to accelerated development of diabetes.
“In contrast, experimental disruption of circadian rhythms in diabetes-prone HIP rats led to accelerated development of diabetes.”
Quote in the paperSubstantial claim - Premisecitation
A light intensity greater than 100 lux creates complete circadian arrhythmicity.
“at a light intensity shown to create complete circadian arrhythmicity (Eastman and Rechtschaffen, 1983).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Eastman and Rechtschaffen, 1983
Not checked in the free run.
- Premisecitation
Disturbance of circadian rhythms due to shift work, sleep loss, or nocturnal lifestyle is an environmental trigger associated with development of type 2 diabetes mellitus.
“One recently described environmental trigger associated with development of T2DM is disturbance of circadian rhythms due to shift work, sleep loss, or nocturnal lifestyle.”
- Also stated in: § Abstract · plain
“Recent epidemiological studies have linked disturbances in circadian rhythms to the development of type 2 diabetes (T2DM), a disease that afflicts nearly 10% of the American population (Bass and Takahashi, 2010; Reddy and O’Neill, 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Bass and Takahashi, 2010
Not checked in the free run.
- cites Reddy and O’Neill, 2010
Not checked in the free run.
- Also stated in: § Abstract · plain
- Interpretationreasoning
The accelerated development of diabetes in HIP rats was primarily due to beta-cell failure.
“implying that accelerated development of diabetes in HIP rats was primarily due to beta-cell failure.”
Quote in the paperSubstantial claim- Rests on an assumption: The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
- Study design and conductown data
During hyperinsulinemic-euglycemic clamps, plasma glucose and insulin concentrations were matched among all experimental light conditions in HIP and WT rats.
“By design, plasma glucose and insulin concentrations were matched during the hyperinsulinemic-euglycemic clamps among all experimental light conditions in HIP and WT rats (Fig. 6A–D).”
Quote in the paperSubstantial claim - Premisecitation
Prediabetic HIP rats at 5 months of age already exhibit a deficit in insulin secretion, similar to prediabetic humans.
“As previously reported (Matveyenko and Butler, 2006), prediabetic HIP rats at 5 months of age (similar to prediabetic humans) already exhibit a deficit in insulin secretion (Fig. 3C–H).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matveyenko and Butler, 2006
Not checked in the free run.
- Premisecitation
The mechanisms underlying the association between circadian rhythm disturbance and type 2 diabetes mellitus are largely unknown.
“However, the underlying mechanisms behind this association are largely unknown.”
- Also stated in: § Abstract · plain
“While epidemiological evidence reveals a link between disturbances in circadian rhythms and T2DM, little is known about the mechanisms underlying this association (Silva et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Silva et al., 2010
Not checked in the free run.
- Also stated in: § Abstract · plain
- Premisecitation
T2DM is characterized by increased beta-cell apoptosis.
“and increased beta-cell apoptosis (Huang et al., 2007; Laybutt et al., 2007).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Huang et al., 2007
Not checked in the free run.
- cites Laybutt et al., 2007
Not checked in the free run.
- Interpretationown data
Disruption of circadian rhythms may increase the risk of type 2 diabetes mellitus by accelerating the loss of beta-cell function and mass characteristic of type 2 diabetes mellitus.
“Disruption of circadian rhythms may increase the risk of T2DM by accelerating the loss of beta-cell function and mass characteristic in T2DM.”
Quote in the paperSubstantial claim- Rests on an assumption: The effects of experimental circadian rhythm disruption in rats are informative about the risk of type 2 diabetes mellitus in humans.
- Premisecitation
Disturbances in circadian rhythms are a predisposing environmental trigger for the development of T2DM.
“Recent studies have described disturbances in circadian rhythms as a predisposing environmental trigger for the development of T2DM (Bass and Takahashi, 2010; Reddy and O’Neill, 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Bass and Takahashi, 2010
Not checked in the free run.
- cites Reddy and O’Neill, 2010
Not checked in the free run.
- Premisecitation
The islet phenotype of diabetic HIP rats closely recapitulates the phenotype of islets in patients with type 2 diabetes mellitus, characterized by loss of beta-cell mass, beta-cell apoptosis, and endoplasmic reticulum stress.
“The islet phenotype of diabetic HIP rats closely recapitulates the phenotype of islets seen in patients with T2DM also characterized by loss of beta-cell mass, beta-cell apoptosis, and ER stress (Huang et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Huang et al., 2007
Not checked in the free run.
- Interpretationown data
The mechanism subserving early-onset diabetes in HIP rats is accelerated loss of beta-cell function and loss of beta-cell mass attributed to increases in beta-cell apoptosis.
“The mechanism subserving early-onset diabetes was due to accelerated loss of beta-cell function and loss of beta-cell mass attributed to increases in beta-cell apoptosis.”
Quote in the paperSubstantial claim - Premisecitation
T2DM is characterized by islet pathology including a deficit in beta-cell mass.
“with characteristic islet pathology, including a deficit in beta-cell mass (Butler et al., 2003; Kloppel et al., 1985)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Butler et al., 2003
Not checked in the free run.
- cites Kloppel et al., 1985
Not checked in the free run.
- Premisecitation
Recent genome-wide association studies have identified a link between variance in the melatonin receptor 1B gene (MTNR1B) and the onset of hyperglycemia and impaired insulin secretion.
“Recent genome-wide association studies have identified a link between variance in the melatonin receptor 1B gene (MTNR1B) and the onset of hyperglycemia and impaired insulin secretion (Bouatia-Naji et al., 2000; Lyssenko et al., 2009; Prokopenko et al., 2009; Ronn et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Bouatia-Naji et al., 2000
Not checked in the free run.
- cites Lyssenko et al., 2009
Not checked in the free run.
- cites Prokopenko et al., 2009
Not checked in the free run.
- Premisecitation
Mutations of CLOCK and BMAL1 in mice (both global and beta-cell specific) result in the development of diabetes and glucose intolerance through the induction of beta-cell failure.
“mutations of CLOCK and BMAL1 in mice (both global and beta-cell specific) result in the development of diabetes and glucose intolerance through the induction of beta-cell failure (Marcheva et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Marcheva et al., 2010
Not checked in the free run.
- Premisecitation
Abrupt shifts in environmental light cycles akin to those employed in the study disrupt the temporal relationship between circadian oscillators within the SCN and peripheral tissues.
“abrupt shifts in environmental light cycles akin to the ones employed in our study have been shown to disrupt the temporal relationship between circadian oscillators within the SCN and peripheral tissues (Filipski et al., 2004; Yamazaki et al., 2000).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Filipski et al., 2004
Not checked in the free run.
- cites Yamazaki et al., 2000
Not checked in the free run.
- Premisecitation
The effects of acute circadian misalignment on glucose tolerance, fasting hyperglycemia, and beta-cell function were independent of changes in feeding and sleep cycles.
“These effects were independent of changes in feeding and sleep cycles (Scheer et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Scheer et al., 2009
Not checked in the free run.
- Premisecitation
Pancreatic islets express robust circadian rhythms in gene expression that are dampened in CLOCK and BMAL1 mutant mice.
“Pancreatic islets express robust circadian rhythms in gene expression that are dampened in CLOCK and BMAL1 mutant mice (Marcheva et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Marcheva et al., 2010
Not checked in the free run.
- Premisecitation
Genetic mutations in core intracellular circadian clock components such as CLOCK and BMAL1 can promote development of diabetes and beta-cell failure.
“genetic mutations in core intracellular circadian clock components such as CLOCK and BMAL1 can also promote development of diabetes and beta-cell failure (Marcheva et al., 2010; Turek et al., 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Marcheva et al., 2010
Not checked in the free run.
- cites Turek et al., 2005
Not checked in the free run.
- Premisecitation
In a subset of individuals (~20%), 10 days of circadian misalignment led to glucose intolerance classified as "diabetic" according to American Diabetes Association diagnostic criteria.
“Scheer and colleagues (2009) show that in a subset of individuals (~20%), 10 days of circadian misalignment led to the level of glucose intolerance classified as “diabetic” according to American Diabetes Association diagnostic criteria.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Scheer and colleagues (2009)
Not checked in the free run.
- Interpretationcitation
Actions of melatonin on beta-cells may be a potential link between circadian rhythm disturbances and increased susceptibility for T2DM.
“These studies imply that actions of melatonin (a key circadian hormone pacemaker) on beta-cells may also be a potential link between circadian rhythm disturbances and increased susceptibility for T2DM.”
Quote in the paperSubstantial claim - Premisecitation
Circulating melatonin levels are diminished in conditions associated with circadian dysregulation and glucose intolerance such as shift work, nocturnal lifestyle, and aging.
“Circulating melatonin levels are diminished in conditions associated with circadian dysregulation and glucose intolerance such as shift work, nocturnal lifestyle, and aging (Karasek, 2004; Mirick and Davis, 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Karasek, 2004
Not checked in the free run.
- cites Mirick and Davis, 2008
Not checked in the free run.
- Premisecitation
Pinealectomy leads to the development of hyperglycemia associated with a decline in beta-cell function.
“Pinealectomy was shown to lead to the development of hyperglycemia associated with a decline in beta-cell function (Diaz and Blazquez, 1986; Mellado et al., 1989).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Diaz and Blazquez, 1986
Not checked in the free run.
- cites Mellado et al., 1989
Not checked in the free run.
- Interpretationown data
Disturbances in circadian rhythms can increase the risk of T2DM development in genetically predisposed individuals.
“Our studies provide potential mechanisms by which disturbances in circadian rhythms can increase the risk of T2DM development in genetically predisposed individuals”
Quote in the paperSubstantial claim- Rests on an assumption: The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
- Rests on an assumption: Circadian disruption induced by LL and 6-h ADV in rats models circadian misalignment in humans, such as that caused by shift work.
- Interpretationown data
Ten weeks of circadian misalignment induced by either exposure to LL or 6-h advance of the light cycle every 3 days leads to accelerated development of diabetes due to deterioration in glucose-stimulated insulin secretion and beta-cell loss in diabetes-prone HIP rats.
“To conclude, we report that 10 weeks of circadian misalignment induced by either exposure to LL or 6-h advance of the light cycle every 3 days leads to the accelerated development of diabetes due to deterioration in glucose-stimulated insulin secretion and beta-cell loss in diabetes-prone HIP rats.”
Quote in the paperSubstantial claim- Rests on an assumption: The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
- Rests on an assumption: Circadian disruption induced by LL and 6-h ADV in rats models circadian misalignment in humans, such as that caused by shift work.
- May combine two claims. 10
- Classified as probably not a substantial claim. 16
May combine two claims.
Findingown dataIn WT rats, beta-cell fractional area and beta-cell mass were not altered in LL and 6-h ADV groups compared to LD.
“in WT rats, beta-cell fractional area, beta-cell mass, and beta-cell turnover (replication and apoptosis) were not altered in LL and 6-h ADV groups compared to LD (Fig. 4A–O and Fig. 5A–F).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataBody weight in the HIP constant-light group tended to be elevated by approximately 5% from 2 to 10 weeks compared with normal light-dark conditions (p = 0.08).
“However, body weight in the HIP LL group tended to be elevated ~5% from 2 to 10 weeks (p = 0.08 for LL vs. LD).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHIP rats develop diabetes by approximately 10 months of age, characterized by progressive loss of pancreatic beta-cell mass and function due to accumulation of toxic human islet amyloid polypeptide oligomers and consequent induction of beta-cell endoplasmic reticulum stress.
“HIP rats develop diabetes by ~10 months of age, characterized by a progressive loss of pancreatic beta-cell mass and function due to accumulation of toxic human islet amyloid polypeptide oligomers and consequent induction of beta-cell endoplasmic reticulum (ER) stress (Haataja et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haataja et al., 2008
Not checked in the free run.
May combine two claims.
PremisecitationAt 3 months of age, HIP rats exhibit fasting glucose levels and beta-cell mass comparable to wild-type rats.
“At this stage, HIP rats exhibit fasting glucose levels and beta-cell mass comparable to WT rats (Butler et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Butler et al., 2004
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationInsulin resistance in type 2 diabetes mellitus primarily manifests at the level of the liver and skeletal muscle, resulting in impaired insulin-stimulated glucose disposal and failure to adequately suppress hepatic glucose production, which contributes to hyperglycemia.
“Insulin resistance in T2DM primarily manifests at the level of the liver and the skeletal muscle, resulting in impaired insulin-stimulated glucose disposal and failure to adequately suppress hepatic glucose production (DeFronzo et al., 1982), which contributes to hyperglycemia.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites DeFronzo et al., 1982
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn those vulnerable to T2DM, hyperglycemia occurs as a consequence of impaired insulin secretion in response to insulin resistance.
“In those vulnerable to T2DM, hyperglycemia occurs as a consequence of impaired insulin secretion in response to insulin resistance (Bergman et al., 1981)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bergman et al., 1981
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost but not all genetic predispositions to type 2 diabetes mellitus appear to be linked to pancreatic beta-cell failure through the regulation of beta-cell function and/or mass.
“Interestingly, most but not all genetic predispositions to T2DM appear to be linked to pancreatic beta-cell failure through the regulation of beta-cell function and/ or mass (Florez, 2008), whereas most environmental triggers such as obesity and physical inactivity have been shown to primarily influence insulin action (Yki-Jarvinen, 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Florez, 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMisalignment of internal circadian oscillators with the external environment leads to deleterious health consequences and is associated with increased morbidity and mortality in humans.
“Misalignment of internal circadian oscillators with the external environment leads to deleterious health consequences and has long been associated with increased morbidity and mortality in humans (Reddy and O’Neill, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Reddy and O’Neill, 2010
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost environmental triggers such as obesity and physical inactivity primarily influence insulin action.
“Interestingly, most but not all genetic predispositions to T2DM appear to be linked to pancreatic beta-cell failure through the regulation of beta-cell function and/ or mass (Florez, 2008), whereas most environmental triggers such as obesity and physical inactivity have been shown to primarily influence insulin action (Yki-Jarvinen, 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yki-Jarvinen, 1995
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe current study's design precludes direct assessment of whether impaired insulin secretion is a direct consequence of beta-cell loss, beta-cell dysfunction, or a combination of both factors.
“with the limitation of precluding direct assessment whether resultant impaired insulin secretion is a direct consequence of beta-cell loss, beta-cell dysfunction, or a combination of both factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in feeding behavior have the potential to uncouple circadian oscillators in peripheral tissues such as the liver and the pancreas from the SCN, via regulation of peripheral clock gene expression.
“Changes in feeding behavior have the potential to uncouple circadian oscillators in the peripheral tissues such as the liver and the pancreas from the SCN, via regulation of peripheral clock gene expression (Damiola et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Damiola et al., 2000
Not checked in the free run.
May combine two claims.
PremisecitationAcute (10 days) circadian misalignment, designed to recapitulate shift work, led to impaired glucose tolerance, fasting hyperglycemia, and diminished beta-cell function.
“a more recent study demonstrated that acute (10 days) circadian misalignment, designed to recapitulate shift work, led to impaired glucose tolerance, fasting hyperglycemia, and diminished beta-cell function (Scheer et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Scheer et al., 2009
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationSleep deprivation caused impaired glucose tolerance with decreased beta-cell glucose responsiveness.
“Spiegel and colleagues (1999) reported that sleep deprivation caused impaired glucose tolerance with decreased beta-cell glucose responsiveness”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Spiegel and colleagues (1999)
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMore than 20% of global gene expression in some peripheral tissues (e.g., liver) is under circadian control.
“Since more than 20% of global gene expression in some peripheral tissues (e.g., liver) is reported to be under circadian control (Reddy et al., 2006)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Reddy et al., 2006
Not checked in the free run.
May combine two claims.
PremisecitationExposure to LL disrupts locomotor activity and feeding patterns.
“Both locomotor activity and feeding patterns are disrupted following exposure to LL (Granados-Fuentes et al., 2004), an observation partially confirmed by our studies (Fig. 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Granados-Fuentes et al., 2004
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningPotential aberration of feeding behavior associated with LL and 6-h ADV might have influenced the study's results on pancreatic beta-cell function and survival.
“Therefore, potential aberration of feeding behavior associated with LL and 6-h ADV might have influenced our results as it pertains to effects on pancreatic beta-cell function and survival.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe mechanism of beta-cell failure in T2DM shares many parallels with neurodegenerative diseases such as Alzheimer disease.
“the mechanism of beta-cell failure in T2DM shares many parallels with neurodegenerative diseases such as Alzheimer disease (Haataja et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Haataja et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSleep loss in humans is associated with an increase in food intake and preference for high-energy foods, which likely contributes to increased risk for obesity, insulin resistance, and subsequently T2DM.
“sleep loss in humans is associated with an increase in food intake and preference for high-energy foods, which likely contributes to increased risk for obesity, insulin resistance, and, subsequently, T2DM (Spiegel et al., 2005; Van Cauter et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Spiegel et al., 2005
Not checked in the free run.
- cites Van Cauter et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA role for melatonin in the regulation of glucose homeostasis and beta-cell function was first proposed more than 50 years ago.
“a role for melatonin in the regulation of glucose homeostasis and beta-cell function was first proposed more than 50 years ago (Milcou et al., 1957).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Milcou et al., 1957
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningConditions of circadian misalignment that have become commonplace in our "24/7" society may have severe health consequences.
“emphasize that conditions of circadian misalignment that have become commonplace in our “24/7” society may have severe health consequences.”
Quote in the paperNot a substantial claim- Rests on an assumption: Circadian disruption induced by LL and 6-h ADV in rats models circadian misalignment in humans, such as that caused by shift work.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMelatonin promotes cell survival, particularly in response to Alzheimer beta-amyloid-induced cell death.
“melatonin has been shown to promote cell survival, particularly in response to Alzheimer beta-amyloid-induced cell death (Jang et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jang et al., 2005
Not checked in the free run.
May combine two claims.
InterpretationreasoningMelatonin may play a role in the regulation of beta-cell mass and/or function, and disruption of beta-cell melatonin signaling may contribute to development of T2DM associated with circadian rhythm disorders.
“Collectively, these data imply a possible role for melatonin in the regulation of beta-cell mass and/or function and raise the possibility that disruption of beta-cell melatonin signaling may contribute to development of T2DM associated with circadian rhythm disorders.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The effects of experimental circadian rhythm disruption in rats are informative about the risk of type 2 diabetes mellitus in humans.
“Disruption of circadian rhythms may increase the risk of T2DM by accelerating the loss of beta-cell function and mass characteristic in T2DM.”
“To address this, the authors examined the metabolic and physiological consequences of experimentally controlled circadian rhythm disruption in wild-type (WT) Sprague Dawley and diabetes-prone human islet amyloid polypeptide transgenic (HIP) rats: a validated model of T2DM.”
The paper relies on this without support.
The HIP rat is a valid model of human T2DM in which beta-cell failure is the primary metabolic defect.
“the primary metabolic defect in HIP rats relates to beta-cell failure”
The paper relies on this without support.
Circadian disruption induced by LL and 6-h ADV in rats models circadian misalignment in humans, such as that caused by shift work.
“conditions of circadian misalignment that have become commonplace in our “24/7” society may have severe health consequences.”
The paper relies on this without support.
The observed effects on pancreatic beta-cell function and survival are due to circadian disruption rather than other effects of the light schedules.
“potential aberration of feeding behavior associated with LL and 6-h ADV might have influenced our results as it pertains to effects on pancreatic beta-cell function and survival.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Shift workers or people who sleep poorly are more likely to develop obesity and T2DM due to circadian clock disruption.
“Shift workers or people who sleep poorly are more likely to develop obesity and T2DM due to circadian clock disruption 31, 32, 33, 34, 35, 36, 37.”
From The Circadian Syndrome: is the Metabolic Syndrome and much more! (2019) · cites this paper as [33]
Circadian disruption may accelerate the development of type 2 diabetes mellitus in diabetes-prone individuals.
“it is already known that circadian disruption may accelerate the development of T2DM in diabetes-prone individuals.40”
From Shift work and diabetes mellitus: a meta-analysis of observational studies (2015) · cites this paper as [40]
In rats prone to type 2 diabetes, phase advancing the light/dark cycle by 6 h every 3 days for 10 weeks accelerates the onset of type 2 diabetes by causing a hastened loss of beta-cell function and mass.
“It has also been demonstrated, in rats prone to the development of type 2 diabetes, that phase advancing the light/dark cycle by 6 h every 3 days for 10 weeks accelerates the onset of type 2 diabetes by causing a hastened loss of beta-cell function and mass (Gale et al., 2011).”
From The impact of the circadian timing system on cardiovascular and metabolic function (2012) · cites this paper as Gale et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Light-cycle schedule does not return to baseline every 15 days
MinorA 6-hour advance every 3 days requires four advances, or 12 days, to complete a 24-hour cycle and return to the original light schedule. After 15 days, five advances would total 30 hours, leaving the schedule 6 hours from baseline.
“Animals in the 6-h advance group shifted 6 h every 3 days and thus every 15 days returned to the “original” baseline LD cycle (lights on at 0600 h, lights off at 1800 h).”
“6-h advance of the LD cycle every 3 days designed to simulate chronic jet leg”
Bouatia-Naji citation year conflicts with reference list
MinorThe in-text citation gives 2000, but the corresponding reference entry gives 2009.
“(Bouatia-Naji et al., 2000; Lyssenko et al., 2009; Prokopenko et al., 2009; Ronn et al., 2009)”
“3. Bouatia-Naji N Bonnefond A Cavalcanti-Proenca C Sparso T Holmkvist J Marchand M Delplanque J Lobbens S Rocheleau G Durand E 2009 A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk Nat Genet 41 89 94 19060909”
Cites
Coordination of circadian timing in mammals
Reppert, S. M., & Weaver, D. R. (2002) · Nature · doi:10.1038/nature00965 · Cited by 4,379 · see citing works
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · see citing works
Impact of sleep debt on metabolic and endocrine function
Spiegel, K., Leproult, R., & Van Cauter, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01376-8 · Cited by 3,668 · see citing works
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016 · see citing works
Obesity and Metabolic Syndrome in Circadian <i>Clock</i> Mutant Mice
Turek, F. W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D. R., et al. (2005) · Science · doi:10.1126/science.1108750 · Cited by 2,485 · see citing works
Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394 · see citing works
Adverse metabolic and cardiovascular consequences of circadian misalignment
Scheer, F. A. J. L., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808180106 · Cited by 2,351 · see citing works
Circadian integration of metabolism and energetics
Bass, J., & Takahashi, J. S. (2010) · Science · doi:10.1126/science.1195027 · Cited by 1,910 · see citing works
Resetting central and peripheral circadian oscillators in transgenic rats
Yamazaki, S., Numano, R., Abe, M., Hida, A., Takahashi, R.-I., Ueda, M., Block, G. D., Sakaki, Y., Menaker, M., & Tei, H. (2000) · Science · doi:10.1126/science.288.5466.682 · Cited by 1,907 · see citing works
Self-citationObesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808 · see citing works
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 2× · see citing works
“In those vulnerable to T2DM, hyperglycemia occurs as a consequence of impaired insulin secretion in response to insulin resistance (Bergman et al., 1981) with characteristic islet pathology, including a deficit in beta-cell mass (Butler et al., 2003; Kloppel et al., 1985) and increased beta-cell…”
BackgroundDisruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes
Marcheva, B., Ramsey, K. M., Buhr, E. D., Kobayashi, Y., Su, H., Ko, C. H., Ivanova, G., Omura, C., Mo, S., Vitaterna, M. H., et al. (2010) · Nature · doi:10.1038/nature09253 · Cited by 1,525 · see citing works
Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes
Spiegel, K., Knutson, K., Leproult, R., Tasali, E., & Cauter, E. V. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00660.2005 · Cited by 1,175 · see citing works
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917 · see citing works
Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes
Laybutt, D. R., Preston, A. M., Åkerfeldt, M. C., Kench, J. G., Busch, A. K., Biankin, A. V., & Biden, T. J. (2007) · Diabetologia · doi:10.1007/s00125-006-0590-z · Cited by 830 · see citing works
Metabolic consequences of sleep and sleep loss
Van Cauter, E., Spiegel, K., Tasali, E., & Leproult, R. (2008) · Sleep Medicine · doi:10.1016/s1389-9457(08)70013-3 · Cited by 812 · see citing works
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Þorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A., Aulchenko, Y. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.290 · Cited by 743 · see citing works
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742 · see citing works
Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited.
Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. (1985) · Survey and Synthesis of Pathology Research · doi:10.1159/000156969 · Cited by 645 · see citing works
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612 · see citing works
Bouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611 · see citing works
Circadian orchestration of the hepatic proteome
Reddy, A. B., Karp, N. A., Maywood, E. S., Sage, E. A., Deery, M., O'Neill, J. S., Wong, G. K. Y., Chesham, J., Odell, M., Lilley, K. S., et al. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.026 · Cited by 548 · see citing works
DeFronzo, R. A., Simonson, D. C., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 539 · see citing works
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483 · see citing works
Huang, C.-J., Lin, C., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db07-0197 · Cited by 417 · see citing works
Effects of Chronic Jet Lag on Tumor Progression in Mice
Filipski, E., Delaunay, F., King, V. M., Wu, M., Claustrat, B., Gréchez‐Cassiau, A., Guettier, C., Hastings, M. H., & Lévi, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0674 · Cited by 416 · see citing works
Metabolism and the Control of Circadian Rhythms
Rutter, J. P., Reick, M., & McKnight, S. L. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.090501.142857 · Cited by 401 · see citing works
Melatonin, human aging, and age-related diseases
Karasek, M. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.012 · Cited by 380 · see citing works
Florez, J. C. (2008) · Diabetologia · doi:10.1007/s00125-008-1025-9 · Cited by 290 · see citing works
Butler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267 · see citing works
Healthy clocks, healthy body, healthy mind
Reddy, A. B., & O'Neill, J. S. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.10.005 · Cited by 182 · see citing works
Melatonin as a biomarker of circadian dysregulation
Mirick, D. K., & Davis, S. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0605 · Cited by 176 · see citing works
Granados‐Fuentes, D., Prolo, L. M., Abraham, U., & Herzog, E. D. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4002-03.2004 · Cited by 156 · see citing works
Matveyenko, A. V., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db05-1672 · Cited by 142 · see citing works
Self-citationCircadian temperature and wake rhythms of rats exposed to prolonged continuous illumination
Eastman, C. I., & Rechtschaffen, A. (1983) · Physiology & Behavior · doi:10.1016/0031-9384(83)90061-6 · Cited by 139 · see citing works
Role of insulin resistance in the pathogenesis of NIDDM
Yki-J�rvinen, H. (1995) · Diabetologia · doi:10.1007/bf00400597 · Cited by 116 · see citing works
Rönn, T., Wen, J., Yang, Z., Lü, B., Du, Y., Groop, L., Hu, R., & Ling, C. (2009) · Diabetologia · doi:10.1007/s00125-009-1297-8 · Cited by 108 · see citing works
Effect of Pinealectomy on Plasma Glucose, Insulin and Glucagon Levels in the Rat
Dı́az, B., & Blázquez, E. (1986) · Hormone and Metabolic Research · doi:10.1055/s-2007-1012279 · Cited by 98 · see citing works
Melatonin attenuates amyloid beta25–35-induced apoptosis in mouse microglial BV2 cells
Jang, M.-H., Jung, S.-B., Lee, M., Kim, C., Oh, Y.-T., Kang, I., Kim, J., & Kim, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.003 · Cited by 93 · see citing works
Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90335.2008 · Cited by 47 · see citing works
Self-citationMellado, C., Rodríguez, V., de Diego, J. G., et al. (1989) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1989.tb00425.x · Cited by 32 · see citing works
No time to lose: workshop on circadian rhythms and metabolic diseasePreprint
Silva, C. M., Sato, S. M., & Margolis, R. (2010) · Genes & Development · doi:10.1101/gad.1948310 · Cited by 16 · see citing works
Sm, M., Vrejoin, G., Marcean, R., & Nanu, L. (1957) · PubMed · Cited by 10 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Kloppel G, 1985, Surv Synth Pathol Res, 4, 110
- Milcou SM, 1957, Ann Endocrinol (Paris), 18, 621
Cited by
Sorted by citations
Shift work and diabetes mellitus: a meta-analysis of observational studies
Gan, Y., Yang, C., Tong, X., Sun, H., Cong, Y., Yin, X., Li, L., Cao, S., Dong, X., Gong, Y., et al. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102150 · Cited by 526 · see citing works
Morris, C. J., Yang, J. N., Garcia, J. I., Myers, S., Bozzi, I., Wang, W., Buxton, O. M., Shea, S. A., & Scheer, F. A. J. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418955112 · Cited by 523 · see citing works
Linking neural activity and molecular oscillations in the SCN
Colwell, C. S. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3086 · Cited by 474 · see citing works
Self-citationThe Circadian Syndrome: is the Metabolic Syndrome and much more!
Zimmet, P., Alberti, K. G. M. M., Stern, N., Bilu, C., El‐Osta, A., Einat, H., & Kronfeld‐Schor, N. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12924 · Cited by 387 · see citing works
Morris, C. J., Purvis, T. E., Mistretta, J., & Scheer, F. A. J. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3924 · Cited by 262 · see citing works
Coomans, C. P., van den Berg, S. A. A., Houben, T., van Klinken, J., van den Berg, R., Pronk, A. C. M., Havekes, L. M., Romijn, J. A., van Dijk, K. W., Biermasz, N. R., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-210898 · Cited by 252 · see citing works
Reynolds, A. C., Dorrian, J., Liu, P. Y., Van Dongen, H. P. A., Wittert, G. A., Harmer, L. J., & Banks, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041218 · Cited by 233 · see citing works
Moon, S., Kang, J., Kim, S. H., Chung, H. S., Kim, Y. J., Yu, J. M., Cho, S. T., Oh, C.-M., & Kim, T. (2020) · Nutrients · doi:10.3390/nu12051267 · Cited by 231 · see citing works
The impact of the circadian timing system on cardiovascular and metabolic function
Morris, C. J., Yang, J. N., & Scheer, F. A. J. L. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59427-3.00019-8 · Cited by 215 · see citing works
Chrononutrition in the management of diabetes
Henry, C. J., Kaur, B., & Quek, R. Y. C. (2020) · Nutrition & Diabetes · doi:10.1038/s41387-020-0109-6 · Cited by 174 · see citing works
Kivimäki, M., Batty, G. D., & Hublin, C. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001138 · Cited by 110 · see citing works
Activation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84 · see citing works
Exposure to shift work as a risk factor for diabetes
Monk, T. H., & Buysse, D. J. (2013) · Journal of Biological Rhythms · doi:10.1177/0748730413506557 · Cited by 77 · see citing works
- Authors
- Gale, J. E., Cox, H. I., Qian, J., Block, G. D., Colwell, C. S., & Matveyenko, A. V.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Matveyenko, Aleksey V.
- Venue
- Journal of Biological Rhythms
- Publisher
- SAGE Publications
- Published
- 2011-09-15
- Volume
- 26
- Issue
- 5
- Pages
- 423-433
- ISSN
- 0748-7304 (ISSN-L)
- 1552-4531
- PMC
- PMC3359760
- OpenAlex
- W2021990756
- Semantic Scholar
- 156f0efdddd9aef7987102b1ef9b99213486d7ac
- Cited by
- 247
- References
- 43
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 15 · 2023: 14 · 2022: 8 · 2021: 19 · 2020: 27 · 2019: 18 · 2018: 20 · 2017: 23 · 2016: 13 · 2015: 27 · 2014: 16 · 2013: 14 · 2012: 10
- FWCI
- 13.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Biological Rhythms (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Larry L. Hillblom Foundation
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, K01DK089003, P30DK063491, DK089003)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and Work-Related Fatigue
- Keywords
- circadian rhythm disruption, type 2 diabetes, pancreatic beta-cell loss, beta-cell dysfunction, beta-cell apoptosis, beta-cell mass, insulin sensitivity, constant light, glucose-stimulated insulin secretion
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Circadian Rhythm, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Male, Motor Activity, Rats, Sprague-Dawley, Photoperiod, Insulin-Secreting Cells, Rats, Rats, Transgenic, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review